INSM vs JAZZ · rev $731.5M vs P/E 1988, rev $2.28B
Insmed Inc (INSM) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Insmed Inc (INSM) is a biotechnology company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported INSM revenue for 2026-06-30 was $731.5M. Net income was -$176.8M. INSM currently screens at market cap $20.42B.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
INSM currently screens at market cap $20.42B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the INSM and JAZZ stock pages for the full models.
Not investment advice.